
SentinelOne Joins AWS ISV Workload Migration Program
SentinelOne has announced that it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Workload Migration Program, a program that supports AWS Partner Network (APN) members with a Software-as-a-Service (SaaS) offering on AWS, to drive and deliver workload migrations.
By participating in the AWS ISV Workload Migration Program, SentinelOne will offer AWS customers accelerated secure cloud migrations support to help them rapidly migrate securely with modern, AI-powered CNAPP capabilities. With the new program, SentinelOne will use incremental funding, technical support, and go-to-market support from AWS to ensure customers benefit from reduced migration timelines and costs as they transition their software to the cloud. With SentinelOne's AI-powered Singularity Cloud Security, they also gain real-time visibility and protection throughout the migration journey—whether moving from on-premises or another cloud environment—ensuring a secure and seamless transition to AWS.
' Through our participation in the AWS ISV Workload Migration Program, SentinelOne is helping customers accelerate secure cloud migrations with end-to-end protection and visibility ,' said Ric Smith, President of Product, Technology, and Operations, SentinelOne. ' Whether moving from on-prem or another cloud to AWS, organizations can count on us to deliver the security they need throughout their journey–realizing the performance, speed, agility, and cost benefits of the cloud. '
SentinelOne's Singularity Cloud Security combines agentless and agent-based protection to provide deep visibility, continuous posture management, and real-time threat detection across cloud environments. Whether customers are migrating from on-premises or other cloud providers, SentinelOne empowers them to maintain end-to-end visibility and protection across current and future environments, making it an ideal solution for today's hybrid operating models. Through close collaboration with channel, services, and technical partners, SentinelOne integrates seamlessly into broader migration project teams, helping customers move faster, reduce risk, and confidently embrace the speed and scale of the cloud.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
a day ago
- Zawya
IntelliDent AI and Manipal Academy of Higher Education sign strategic MoU to transform healthcare through AI
IntelliDent AI, a Dubai-based healthtech innovator transforming dentistry through artificial intelligence, has signed a Memorandum of Understanding (MoU) with the Manipal Academy of Higher Education (MAHE), India—an Institution of Eminence and global academic leader. This strategic three-year partnership aims to accelerate advancements in AI-powered oral healthcare through collaborative research, education, and entrepreneurship. The MoU, executed on behalf of MAHE's Manipal College of Dental Sciences (MCODS), Mangalore, lays the foundation for academic-industry cooperation focused on developing future-ready dental AI solutions and equipping students with the technical and entrepreneurial skills to lead the next era of digital healthcare. Key Pillars of the Collaboration: Joint Research Programs: MAHE and IntelliDent will co-develop research initiatives in AI-driven diagnostics, public health, and healthcare innovation—contributing to academic publications, patents, and whitepapers. Training & Internships: MAHE students will gain hands-on exposure through internships and mentorships at IntelliDent, supported by industry insights, guest lectures, and workshops. Entrepreneurial Development: The collaboration will foster cohort-based learning modules, innovation hackathons, and startup support to accelerate the commercialization of student-led healthtech ideas. Knowledge Exchange: Faculty, researchers, and industry experts will engage in reciprocal learning and cross-training to fuel innovation, skill-building, and strategic growth. Affaan Shaikh, Founder & CEO of IntelliDent AI, shared his thoughts on the collaboration: 'This partnership is about reimagining healthcare through ethical AI and innovation. We are thrilled to work alongside one of India's top institutions to shape the next generation of AI health leaders.' The MoU was signed by Dr. Giridhar P. Kini, Registrar of MAHE, and Mr. Affaan Shaikh, with active engagement from academic and innovation stakeholders from both organizations. This collaboration underscores IntelliDent AI's mission to scale accessible, AI-powered dental care globally and MAHE's continued commitment to integrating technology, research, and impact-driven education in the healthcare ecosystem. Together, MAHE and IntelliDent AI are building a bold future where education, innovation, and oral health equity intersect.


Arabian Post
2 days ago
- Arabian Post
AI‑Powered Phage Therapy Set to Tackle Antibiotic Resistance
Phagos, a Paris‑based biotech startup, is deploying an artificial‑intelligence model built on Amazon Web Services to accurately match bacteriophages with antibiotic‑resistant bacterial strains. This development marks a pivotal shift from arbitrary trial‑and‑error methods to precision medicine in combating infections that claim an estimated one million lives annually. The challenge of antibiotic resistance has spurred Phagos, co‑founded by microbiologist Adèle James and economist Alexandros Pantalis, to pursue alternative therapies. Phages are viruses that specifically infect bacteria, a property that enables targeted treatment without disrupting beneficial microorganisms. But identifying the right phage for a given pathogen has traditionally required labour‑intensive screening of millions of combinations. Phagos is leveraging AWS's Generative AI Accelerator Programme, which has provided them with cloud credits, embedded AWS architects and machine‑learning engineers, and dedicated mentorship, to build a generative AI platform capable of predicting effective pairings between phages and bacterial strains. The AI model has been trained on datasets from public repositories and proprietary lab results. ADVERTISEMENT 'We can now read into the DNA and see if there's going to be an interaction between a phage and a bacterium,' Pantalis explained. This capability bypasses exhaustive wet‑lab testing and accelerates the discovery pipeline. Phagos's strategy involves initial trials in animal health—shrimp, chicken, bovine, swine—with phages administered through water systems to curb infections in farm environments. James noted that reducing antibiotic use in livestock is critical, as drug‑resistant bacteria generated in farms can transfer to humans via environmental pathways. The startup's first validation came from a collaboration with an oyster farmer in France, where AI‑matched phages slashed mortality by 40 per cent. Technical infrastructure from AWS played a crucial role, with cloud experts helping to refine the system and scale it efficiently. 'We became much faster, and spent way less time figuring out how to set up our infrastructure,' James said. Globally, the antibiotic resistance crisis is projected to cause more deaths than cancer by mid‑century, with economic impacts exceeding US$1.5 trillion. By automating phage matching, Phagos aims to create personalised and adaptive therapies that evolve in tandem with bacterial mutations. Participation in AWS's 2024 accelerator—which selected just 80 startups from over 4,700 applicants—has provided Phagos not only with technical and financial support, but also exposure to industry networks and potential funding sources. The platform-as‑a‑service model being developed by Phagos positions the company as a pioneer in AI‑driven microbiological model building. One quarter of its team now focuses exclusively on data and machine learning, a rarity in biotech. Expansion plans are underway: the company intends to move into human therapeutic applications by 2030, while continuing its work in agriculture. It is also advancing bespoke phage therapies, distinguishing itself from generic phage cocktails pursued by competitors. While obstacles remain—such as regulatory pathways for phage-based treatments and the complexity of bacterial ecosystems—Phagos believes its AI model and cloud infrastructure provide a scalable solution. Each new phage cocktail generates data that feeds into the platform, enhancing future predictions.


Khaleej Times
2 days ago
- Khaleej Times
Apple executives held internal talks about buying Perplexity: Reports
Apple executives have held internal talks about potentially bidding for artificial intelligence startup Perplexity, Bloomberg News reported on Friday, citing people with knowledge of the matter. The discussions are at an early stage and may not lead to an offer, the report said, adding that the tech behemoth's executives have not discussed a bid with Perplexity's management. "We have no knowledge of any current or future MA discussions involving Perplexity," Perplexity said in response to a Reuters' request for comment. Apple did not immediately respond to a Reuters' request for comment. Big tech companies are doubling down on investments to enhance AI capabilities and support growing demand for AI-powered services to maintain competitive leadership in the rapidly evolving tech landscape. Bloomberg News also reported on Friday that Meta Platforms tried to buy Perplexity earlier this year. Meta announced a $14.8 billion investment in Scale AI last week and hired Scale AI CEO Alexandr Wang to lead its new superintelligence unit. Adrian Perica, Apple's head of mergers and acquisitions, has weighed the idea with services chief Eddy Cue and top AI decision-makers, as per the report. The iPhone maker reportedly plans to integrate AI-driven search capabilities, such as Perplexity AI, into its Safari browser, potentially moving away from its longstanding partnership with Alphabet's Google. Banning Google from paying companies to make it their default search engine is one of the remedies proposed by the US Department of Justice to break up its dominance in online search. While traditional search engines such as Google still dominate global market share, AI-powered search options including Perplexity and ChatGPT are gaining prominence and seeing rising user adoption, especially among younger generations. Perplexity recently completed a funding round that valued it at $14 billion, Bloomberg News reported. A deal close to that would be Apple's largest acquisition so far. The Nvidia-backed startup provides AI search tools that deliver information summaries to users, similar to OpenAI's ChatGPT and Google's Gemini.